SQZ News and Press, SQZ Biotechnologies Company From 05/25/22

The following slide deck was published by SQZ Biotechnologies Company in conjunction with this event. For further details see: SQZ Biotechnologies (SQZ) Investor presentations - Slideshow

Average Processing Time Per Batch Less Than 6 Hours – a 55% Reduction with Comparable or Improved Product Metrics First Clinical Use Planned for SQZ ® TACs in Celiac Disease with IND Submission Anticipated in 1H 2023 Preclinical Data on Hematopoieti...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

SQZ Biotechnologies press release (NYSE:SQZ): Q1 GAAP EPS of -$0.75 misses by $0.04. Revenue of $2.87M (-47.3% Y/Y) misses by $2.06M. For further details see: SQZ Biotechnologies GAAP EPS of -$0.75 misses by $0.04, revenue of $2.87M misses by $2.06M

Granted FDA Fast Track Designation for Lead APC Clinical Candidate Received FDA IND Clearance to Initiate Phase 1/2 Clinical Trial of Next Generation eAPC Therapeutic Candidate for HPV16+ Solid Tumors Published Peer Reviewed, Comprehensive Preclinical Research Su...

SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that the company will host a live R&D investor event with optional virtual participation on Thursday, May 19, 2022, from 4:05 - 5:30 p.m...

SQZ’s Point-of-Care (POC) Manufacturing Platform Shows Promising Results with Ability to Produce Cell Therapies at Scale in Under 10 Hours Co-Development of Research-Use-Only System with STEMCELL Technologies to Help Drive Cell Therapy Innovation by the Broader Scie...

Gainers: Statera Biopharma (STAB) +132%. SQZ Biotechnologies (SQZ) +35%. RCM Technologies (RCMT) +24%. Integrated Media Technology (IMTE) +21%. Ocwen Financial (OCN) +21%. Pitney Bowes (PBI) +20%. Allego (ALLG) +18%. PTC (PTC) +16%. LSI Industries (LYTS) +16%. XBiotech (XBIT) +...

Gainers: SQZ Biotechnologies (SQZ) +20%. Amedisys (AMED) +7%. Thermo Fisher Scientific (TMO) +7%. Vascular Biogenics (VBLT) +5%. Opiant Pharmaceuticals (OPNT) +4%. Losers: Teladoc Health (TDOC) -46%. Align Technology (ALGN) -23%. Aptorum Group (APM) -19...

RCM Technologies (RCMT) +25% on Q1 results. SQZ Biotechnologies (SQZ)+17% gets FDA fast track nod for its cell therapy to treat human papillomavirus positive cancers. Meta Platforms (FB) +15% on Q1 results. Atomera (ATOM) +11% on Q1 results. Blackboxstocks (...